Koninklijke DSM (NASDAQ:RDSMY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday. The firm currently has a $24.00 target price on the stock. Zacks Investment Research‘s price objective would indicate a potential upside of 12.04% from the stock’s current price.

According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “

Separately, HSBC Holdings plc initiated coverage on Koninklijke DSM in a research note on Friday, September 1st. They issued a “buy” rating for the company.

Shares of Koninklijke DSM (NASDAQ:RDSMY) traded up 0.14% during midday trading on Thursday, hitting $21.42. 15,321 shares of the company were exchanged. The company has a 50-day moving average of $20.32 and a 200 day moving average of $18.84. Koninklijke DSM has a one year low of $14.50 and a one year high of $21.60. The company has a market capitalization of $14.99 billion and a P/E ratio of 17.68.

ILLEGAL ACTIVITY WARNING: “Koninklijke DSM (RDSMY) Rating Increased to Buy at Zacks Investment Research” was first published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/22/koninklijke-dsm-rdsmy-rating-increased-to-buy-at-zacks-investment-research.html.

About Koninklijke DSM

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company’s segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.

Get a free copy of the Zacks research report on Koninklijke DSM (RDSMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.